Research Peptides Studied in Metabolic and Weight Research: An Overview

Metabolic and weight research is one of the most active areas in peptide science today. This research-only overview groups the compounds most often studied in that space and how they relate.

The incretin agonists

The GLP-1 family anchors this category. Semaglutide is a single GLP-1 agonist, tirzepatide adds the GIP receptor as a dual agonist, and retatrutide adds glucagon as a triple agonist. Our guide to single, dual, and triple agonists maps them.

The amylin pathway

Cagrilintide is a long-acting amylin analogue studied alongside the incretins, since the amylin-plus-GLP-1 combination is a major current research theme.

Mitochondrial and enzyme angles

Beyond the incretins, MOTS-c (a mitochondrial-derived peptide) and 5-Amino-1MQ (an NNMT inhibitor) are studied for metabolic signalling from different mechanistic directions.

Supporting compounds

NAD+ appears frequently in metabolic and cellular-energy research, and growth-hormone-axis peptides such as tesamorelin are sometimes studied in the same context.

Handling across the category

All of these are lyophilised and reconstituted with bacteriostatic water. The GLP-1 reconstitution guide and the reconstitution calculator cover preparation.

Quality and verification

Across a fast-moving category, purity documentation is what separates reliable material from the rest. Understanding how purity is verified helps you compare batches.

Research use only. This article is educational and is not medical, legal, or financial advice. The compounds discussed are not approved for human or veterinary use, consumption, or therapeutic application.